Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Mar;60(3):299-302.
doi: 10.1136/jcp.2006.036665. Epub 2006 May 26.

The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast

Zsolt Hodi  1 , Jayeta Chakrabarti, Andrew H S Lee, John E Ronan, Christopher W Elston, Kwok Leung Cheung, John F R Robertson, Ian O Ellis
Affiliations
Review

The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast

Zsolt Hodi et al. J Clin Pathol. 2007 Mar.

Abstract

Aim: To assess the reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast. Previous studies have mostly been small, with a range of agreement from 62% to 100%.

Methods: Retrospective audit of 338 tumours surgically excised within 60 days of core biopsy, that had had oestrogen receptor assessed on both the core biopsy and tumour specimens. Surgical specimens were incised when fresh to ensure good fixation. External controls including a weakly positive tumour were included in each immunohistochemistry run.

Results: Oestrogen receptor expression was bimodal, with H score in both specimens of either 0 or >50 in 96% of tumours. Using H score cut-off of 10 for positivity, there was an agreement between core and excision in 334 of 338 tumours (98.8%). All discrepancies were between weakly positive and negative tumours. Intratumoral heterogeneity could explain the one tumour that was negative on core and positive on excision. H score tended to be slightly higher on core than excision (means 146 and 136). Better fixation on the core is the most likely explanation for this and for the three tumours that were positive on core and negative on excision. Repeat staining on tumours with discrepant results gave similar results in all except one case. An internal control was present in 97% of excisions and 55% of cores of oestrogen receptor-negative tumours; the internal control stained positively in all except two sections.

Conclusion: Oestrogen receptor can be assessed reliably on needle core biopsies of invasive carcinomas of the breast.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

References

    1. Early Breast Cancer Trialists Collaborative Group Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15‐year survival: an overview of the randomised trials. Lancet 20053651687–1717. - PubMed
    1. Gaskell D J, Hawkins R A, Sangsterl K.et al Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen. Lancet 198911044–1046. - PubMed
    1. Goulding H, Pinder S, Cannon P.et al A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin‐fixed tissue samples. Hum Pathol 199526291–294. - PubMed
    1. Barnes D M, Harris W H, Smith P.et al Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer 1996741445–1451. - PMC - PubMed
    1. Cameron D A, Anderson E D C, Levack P.et al Primary systemic therapy for operable breast cancer–10‐year survival data after chemotherapy and hormone therapy. Br J Cancer 1997761099–1105. - PMC - PubMed